KDSR and leukemia: Leukemias appear to be particularly sensitive because similar effects were seen for KDSR knockout in two additional blood cancer types, Jurkat (T-ALL) and Hut78 cells (T cell lymphoma), but not for four other cell types, 293T cells (transformed embryonic kidney), U251 cells (glioblastoma), SW620 (colon cancer), and A673 (Ewing’s sarcoma).